On Demand Topic: Enhancing The Care Cascade
| Thursday, September 2, 2021 |
| 1:00 AM - 2:00 AM |
Speaker
Ms. Ramona Almeñana
Project Director
CUNY School Of Public Health And Health Policy
#VP26: The Staying Safe Intervention: Contextualizing Knowledge On HCV Transmission, Prevention, And Risk Behaviors Among YPWID
Video / Audio Recordings
Biography
Ramona Almeñana is a Research Project Director at CUNY SPH and also serves as Program Director for her institute's Opioid Overdose Prevention Program, which provides naloxone and opioid recognition and response training to people. Ramona holds an MPA in Public and Nonprofit Management & Policy from New York University.
Ms Mandy Altman
Director
National Hepatitis Corrections Network
#VP55: Blood Borne Infection And Peer Educator Training: Adapting Materials To Deliver Coursework During An Evolving Pandemic
Video / Audio Recordings
Biography
Amanda Altman is the Correctional Health Program Manager for the Hepatitis Education Project (HEP). She plans and teaches classes to people who are incarcerated throughout Washington State and develops educational materials to share with people experiencing incarceration nationally through the National Hepatitis Corrections Network (NHCN).
Ms Mandy Altman
Director
National Hepatitis Corrections Network
#VP27: Viral Hepatitis And HIV Education In A USA Prison System
Video / Audio Recordings
Biography
Mandy Altman is the Director of the National Hepatitis Corrections Network (NHCN) and manages the prison and jail health education programs for the Hepatitis Education Project (HEP) in Seattle, WA. Prior to her current position, Mandy has worked in correctional health education and global health.
Md, Mph Olga Anagnostou
Internist
Greek Organization Against Drugs (okana)
Ms Ilhame Anwar
Phd Student
Inserm Sesstim
#PO22: Factors Associated With HCV Testing In People Who Inject Drugs In France: Results From The PREBUPIV Study
Video / Audio Recordings
Biography
I am a first-year PhD student and I work on hepatitis C care cascade in people who inject drugs, under the supervision of Dr Perrine Roux.
I graduated in midwifery from Montpellier University, and then in public health from Lyon University (France).
Arisha Baig
Student researcher
Austin Hepatitis Centre
#PO20: Electronic Health Engagement Improves Hepatitis C Care Cascade In PWID
Video / Audio Recordings
Biography
30 YEARS OF EXPERIENCE IN CLINICAL HEPATOLOGY AND RESEARCH. SPEACIALIZING IN DEVELOPING CARE MODELS FOR PATIENTS WITH CHRONIC HEPATITIS C AND HISTORY OF POLYSUBSTANCE ABUSE. CLINICAL ASSOCIATE PROFESSOR OF MEDICINE, DELL MEDICAL SCHOOL, AUSTIN, TX.
Dr Tyler Bartholomew
Assistant Professor
University Of Miami
#VP28: Examining Opt-In Versus Routine Opt-Out HIV/HCV Testing At A Syringe Services Program: An Interrupted Time Series Analysis
Biography
PhD Candidate in Prevention Science at the University of Miami Miller School of Medicine. Mr. Bartholomew's research focuses on HIV/HCV prevention interventions, implementation of harm reduction programs, such as SSPs, and policy evaluation of innovative approaches to delivery of care to people who inject drugs.
Ms Marian Bloomfield
CNC Sexual Health/Hepatitis
Justice Health And Forensic Mental Health
#PO23: Integrating All Modalities Of Hepatitis C Testing Into A Comprehensive Model For The NSW Correctional System
Biography
Marian Bloomfield Registered Nurse St Vincent's Hospital Sydney 1982, Bachelor of Nursing 1992 LaTrobe University. Sexual Health Certificate Sydney Hospital 1992.
Marian has been employed by Justice Health and Forensic Mental Health Network since 2001.
Appointed CNC Sexual Health /Hepatitis 2015.
Dr Antonio Boschini
Health Director
San Patrignano Therapeutic Community For Drug Addiction
#PO24: HCV Knowledge And Awareness Among Injecting Drug Users In The Direct Acting Antivirals Era
Video / Audio Recordings
Biography
Antonio Boschini is Infectious Disease specialist and the Chief of the San Patrignano Residential Therapeutic Community (Italy), since 1987. Member of the Italian Ministerial AIDS Council (since 1991), and Italian Ministry of Health Addiction Board (since 2007). Dr Boschini has authored or co-authored 38 scientific publications in peer-reviewed journals.
Dr Daniel Brook
Medical student
Ohio State University
#PO103: The Relationship Between Buprenorphine Maintenance Therapy And Incident Hepatitis C Virus Infection: A Scoping Review
Video / Audio Recordings
Biography
Dan Brook is an MD/PhD student in the Division of Epidemiology in the Ohio State College of Public Health and in the Medical Scientist Training Program at the Ohio State College of Medicine. Dan's research is funded by a National Institute on Drug Abuse National Research Service Award F30 Fellowship.
Ms Marianne Byrne
Clinical Trials Manager
Kirby Institute
#VP29: A Guide To Scale-Up Of Testing And Treatment For Hepatitis C In The Prison Setting: The Stop-C Implementation Toolkit
Video / Audio Recordings
Biography
Marianne is a Clinical Trials Manager and works across both the Kirby Institute and National Drug and Alcohol Research Centre at UNSW Sydney. She currently manages the ASCEND program grant (Advancing the health of people who use drugs: hepatitis C and drug dependence), overseeing multiple community and prison research projects.
Mr Paulo Caldeira
Nurse
Ares Do Pinhal
Dr Chris Cavacuiti
Ceo/ Founder
Truenorthmedical.com
#VP30: Retrospective Review Of The TrueNorth Medical Centres Database In Canada: Assessment Of The Impact Of Simplified Care On Direct-Acting Antivirals Treatment For Hepatitis C Virus Patients In Addiction Care – Northern-HCV
Video / Audio Recordings
Biography
Dr Cavacuiti is on the teaching and research faculty of the DFCM at the University of Toronto. He has been certified in addiction medicine by ABAM and received his Focused Practice Designation in Addiction Medicine from the OMA. He is an elected member of the ASAM Publications Council.
Prof Stéphane Chevaliez
Chief Of Department
Henri Mondor Hospital
#VP31: Assessing Molecular Point-Of-Care Testing And Dried Blood Spot For Hepatitis C Virus Screening In People Who Inject Drugs: A Pilot Study
Video / Audio Recordings
Biography
Stéphane Chevaliez is Professor of Medicine at the University of Paris-Est in Paris. He is also Deputy Director of the National Reference Center for Viral Hepatitis B, C and delta, and a medical virologist in the department of Virology, and a member of INSERM Unit U955
Mrs Kendal Chidwick
Senior Epidemiologist
Nps Medicinewise
#PO25: Cluster RCT Evaluating An Educational Program To Improve Hepatitis C Virus (HCV) Management
Video / Audio Recordings
Biography
Kendal Chidwick is a senior epidemiologist in the Real World Research team at NPS MedicineWise, with more than 15 years of experience working in health and 10 years in research. She has experience analysing large complex primary care datasets in the UK and Australia, leading pharmaco-epidemiological studies based on MedicineInsight.
Ms Romane Close
Knowledge Specialist, Hepatitis C Resource Development
CATIE
#PO26: Needs And Challenges Of Quebec Community Organizations Working With Hepatitis C And Located Outside Of The Montreal Area
Biography
Graduated in 2019 from the University of Montreal with a master in public health, Romane always wanted to start her carrier in the strong community network of Montreal. It has been now more than one year that she works at CAPAHC, a community organization specialized in hepatitis C.
Ms Anna Conway
Research Associate
The Kirby Institute, UNSW
#VP32: Treatment Uptake For Hepatitis C Infection Following An Intervention To Enhance Linkage To Care Among People Who Inject Drugs: The Ethos Engage Study
Video / Audio Recordings
Biography
Anna is a PhD student at the Kirby Institute and Centre for Social Research in Health, UNSW. Her doctoral research investigates health service use by people who use drugs.
Mr Sean Cox
Director Of Prison Services
Hepatitis C Trust
#VP33: Achieving Hepatitis C Virus (HCV) Elimination In Prisons Through ‘HCV Intensive Test And Treat’ (HITT) Interventions
Video / Audio Recordings
Biography
Sean Cox joined the HepC Trust 10/18 bringing >20yrs experience in healthcare provision. He's previously held director roles for other charities which focused on the criminal justice system. Sean led the national role-out of the prison p2p programme and is now national lead on HCV elimination within Health and Justice.
JOAO CURTO
Psychiatrist
Dicad Coimbra
Mr Joshua Dawe
PhD Researcher
University of Bristol
#VP34: Early Hepatitis C Virus Antibody Testing Among Recipients Of Medication For Opioid Use Disorder, Victoria, Australia, 2012 To 2020
Video / Audio Recordings
Biography
Joshua Dawe is an early career public health researcher, with interests in epidemiology and biostatistics.
Joshua joined the Burnet Institute in 2019 in the Disease Elimination program. He is part of the monitoring and evaluation team for Eliminate Hepatitis C Australia, providing data analysis and operational support for project partners.
Dr Benjamin Eckhardt
Assistant Professor
NYU School of Medicine
#PO27: HCV Contact Tracing To Engage Hard To Reach Networks: Findings From The ‘Source Patient Identification And Group Overlap Treatment’ (Spigot) Pilot Program
Speaker Presentation
Video / Audio Recordings
Biography
Benjamin Eckhardt is an Assistant Professor at NYU/Bellevue. His research interest focuses on evaluating models of care to facilitate access, engagement, and retention of active injection drug users in HCV and severe bacterial infection treatment and care.
Dr Shelley Facente
Principal
Facente Consulting
#PO29: Benefits Of Working With A Collective Impact Initiative To Inform Research: Developing Paths To Hepatitis C Elimination For Young Adults Who Inject Drugs
Video / Audio Recordings
Biography
Shelley Facente was trained in sociology at Ithaca College in Ithaca, NY, and subsequently received her Master of Public Health and a PhD in Epidemiology from the University of California, Berkeley. She is part of the backbone support for End Hep C SF, a San Francisco hepatitis C elimination initiative.
Dr Shelley Facente
Principal
Facente Consulting
#PO28: A Causal Analysis Of The Effect Of Routine Abdominal Imaging On Risk Of Hepatocellular Carcinoma For People Living With Chronic Hepatitis C
Video / Audio Recordings
Biography
Shelley Facente is the Principal of the San Francisco Bay Area-based public health consulting firm Facente Consulting, and Coordinating Committee member of End Hep C SF. She has a PhD in Epidemiology and MPH in Health and Social Behavior from UC Berkeley, where she also serves as a staff researcher.
Ms Daisy Gibbs
PhD candidate
NDARC
#VP35: Hepatitis C Virus Cascade Of Care Among People Who Inject Drugs In Australia: Factors Associated With Testing And Treatment In A Universal Healthcare System
Video / Audio Recordings
Biography
Daisy Gibbs joined NDARC in 2018 and has a background in community development. Her primary research interests include illicit drug surveillance and improving the well-being of vulnerable populations through evidence based, targeted service delivery.
Mr. Trevor Goodyear
PhD Student
University Of British Columbia
#PO30: Factors Influencing The Equitable Scale-Up Of Direct-Acting Antiviral Hepatitis C Virus Treatment Among People Who Inject Drugs: A Qualitative Study In British Columbia, Canada
Video / Audio Recordings
Biography
Trevor Goodyear is a registered nurse and Master of Science in Nursing/Master of Public Health student at the University of British Columbia. Trevor is also a graduate academic assistant at the British Columbia Centre on Substance Use, where he collaborates on equity-oriented qualitative research with people who use drugs.
Mr Jack Gunn
Research Assistant
Burnet Institute
Ms. Danielle Guy
Predoctoral Fellow
Barcelona Institute For Global Health
#VP37: Conceptualising Hepatitis C Stigma: A Thematic Synthesis Of Qualitative Research
Video / Audio Recordings
Biography
Danielle is a la Caixa doctoral INPhINIT Fellow at the Barcelona Institute for Global Health (ISGlobal). Her research focuses on how to make harm reduction services more responsive to the needs of women who inject drugs.
Ms Nikitah Habraken
Acting Executive Director
INHSU
#VP38: Enhanced Self-Efficacy For HCV Management Among People Participating An HCV Education Program Focused On Drug And Alcohol And Primary Care Settings
Biography
Emma oversees INHSU’s operational activities, policies, and strategy. She is an experienced program manager specialising in clinical workforce development, and has expertise in governance, business development and strategic planning.
Dr Kevin Jia
Junior Medical Officer
Bankstown-Lidcombe Hospital
#PO31: Barriers And Facilitators Affecting Uptake Of Hepatitis C Treatment Amongst Patients On Methadone In Greater Western Sydney
Video / Audio Recordings
Biography
Kevin Jia completed his degree in medicine from Western Sydney University in 2020 and is currently a JMO at Bankstown-Lidcombe Hospital, with interests in hepatology, gastroenterology and public health. Harsha Venkateshan completed his degree in medicine from Western Sydney University in 2020 and has interests in public health and policy.
Dr Reyes-Urueña Juliana
Epidemiologist
Ceeiscat
#VP51: HCV Cascade Of Care Of People Admitted To Drug Treatment (2015-2019) In Catalonia
Video / Audio Recordings
Biography
Juliana Reyes–Urueña, PhD, MPH, MsC, M.D, is an epidemiologist. She posses a Bachelor of Science in Medicine, Master degree in Tropical Medicine and International Health, and in Public health, and is a specialist of Preventive Medicine and Public Health. She holds a Ph.D. in Methodology of Biomedical Research and PH.
Dr Lise Lafferty
Senior Research Fellow
Centre for Social Research in Health
#VP39: Patient Perceptions Of Acceptability Of Hepatitis C Point-Of-Care Testing At A Reception Prison
Video / Audio Recordings
Biography
Dr Lise Lafferty is a Research Fellow at UNSW Sydney with positions at Centre for Social Research in Health and The Kirby Institute. Her research interests include lived experiences of people living with chronic illnesses (with a focus on people in prison living with HCV) and addressing barriers to care.
Mr Ned Latham
Research Assistant
Burnet Institute
#VP40: Using Historic Notification Data To Increase Access To The Hepatitis C Cure: Key Stakeholder Perspectives
Video / Audio Recordings
Biography
Ned is a junior doctor and research assistant with interests in hepatitis C, implementation science and consumer advocacy. In 2017, he completed an honours thesis examining the acceptability of rapid, point-of-care hepatitis C testing for people who inject drugs. Since then, Ned has continued work within the viral hepatitis group.
PhD Anthony Lee
Scientist
UAB School of Medicine, Division of Infectious Diseases
#VP138: Lessons learned in Alabama’s HCV work with the PWID population
Video / Audio Recordings
Biography
Dr. Lee is a Scientist in the Division of Infectious Diseases. He has served as the director for community prevention in infectious diseases. His primary area of work involves scaling up opt out EMR routine screening for HIV and HCV.
Dr Amy Malaguti
Health Psychologist
NHS Tayside / University of Dundee
#PO32: A Qualitative Study Investigating The Lived Experience Of Hepatitis C Diagnosis, Treatment And Cure In People Who Inject Drugs On Direct Acting Antiviral Treatment
Biography
Amy is a Health Psychologist with an interest in sexual health, BBVs and substance use. She is a recent PhD graduate, works as a Health Psychologist with NHS Tayside's Drug & Alcohol Recovery Service and is researching overdose prevention with the University of Dundee and the Scottish Drug Death Taskforce.
Dr Alison Marshall
Research Fellow
UNSW/Kirby Institute
#VP42: Willingness Among Clients To Participate In A Randomised Controlled Trial Involving Financial Incentives To Initiate Hepatitis C Treatment – A Pilot Study
Video / Audio Recordings
Biography
Alison Marshall is a postdoctoral fellow based at the Kirby Institute and the Centre for Social Research in Health, UNSW Sydney. Her research interests involve improving access to hepatitis C treatment for persons with a history of injection drug use.
Ms. Stefanie Materniak
Research Associated
Infectious Disease Research Unit (Horizon Health Network)
#PO33: Ensuring Appropriate Follow-Up And Access To Screening For People At Ongoing Risk For HCV Re-Infection Post-Clearance; A Neglected Step In The HCV Cascade Of Care
Video / Audio Recordings
Biography
Stefanie Materniak is the executive director of RECAP, a non-profit harm reduction clinic in New Brunswick, Canada. She holds her Masters of Science in Epidemiology from the London School of Hygiene and Tropical Medicine.
Ms. April Mazzuca
Phd Candidate
Ubc School Of Population And Public Health
#VP139: CEDAR PROJECT HCV BLANKET PROGRAM: EXPLORING EXPERIENCES AND IMPACT OF A CULTURALLY-SAFE CASE MANAGEMENT APPROACH IN SUPPORTING HCV TREATMENT AMONG INDIGENOUS PEOPLE USE(D) DRUGS IN BRITISH COLUMBIA, CANADA.
Video / Audio Recordings
Biography
April Mazzuca is a PhD candidate with the Cedar Project's HCV Blanket Program at University of British Columbia
Tina McHugh
Infectious Diseases Study Coordinator
University College Dublin
#PO34: Community Based Peer Facilitated Hepatitis C Point Of Care Testing Project Dublin
Biography
Dr. John (Jack) Lambert is Consultant in Infectious diseases in Dublin at the Mater Misericordiae University Hospital and Professor at UCD School of Medicine. Dr. Lambert has a 25 years experience in Infectious Diseases covering HIV, Hepatitis C, and other disease areas.
Ms Leah McLeod
Communications Lead
Nsw Users & Aids Association
#PO35: Insider’s News: Peer Magazine Is A Hep C Game Changer For NSW Jails
Biography
Leah McLeod is the Communications Lead at peer organisation NSW Users & AIDS Association (NUAA). Leah is a person who injects drugs and has worked in harm reduction for over 15 years, 8 of those with NUAA. Her back story is in health policy and art and design.
Ms Cristiana Merendeiro
Project Manager
CRESCER - Community Intervention Association
#PO36: Point-Of-Care Screening Combined With Nursing And Peer-Based Outreach Work To Enhance Testing And Treatment For Hepatitis C Among People Who Use Drugs, People Who Experience Homelessness, And Migrants: The Reach_U Project
Video / Audio Recordings
Biography
Neuropsychologist, working in harm reduction since 2015. Currently coordinating a Housing First program for PWUD and experience homelessness, a point-of-care HCV screening and treatment combined with outreach work and a community-based research group in CRESCER, a NGO in Portugal. In the past, has worked in a mobile low-threshold methadone program.
Dr Håvard Midgard
senior consultant / associate professor
Oslo University Hospital
#VP44: Opportunistic Treatment Of Hepatitis C Virus Infection (Opportuni-C): Study Protocol For A Pragmatic Stepped Wedge Cluster Randomized Trial Of Immediate Versus Outpatient Treatment Initiation Among Hospitalized People Who Inject Drugs
Video / Audio Recordings
Biography
Håvard Midgard is a specialist in gastroenterology and postdoctoral researcher at Oslo University Hospital and Akershus University Hospital. His research interests include HCV epidemiology, models of care, and general hepatology. He is a founding member of the Norwegian Center for HCV elimination and a former INHSU board member.
Mr Gareth Myring
Research Associate
University of Bristol
#VP140: Cost-Effectiveness of Pharmacy-led Versus Conventionally Delivered Antiviral Treatment for Hepatitis C in Patients Receiving Opioid Substitution Therapy: An Economic Evaluation Alongside a Pragmatic Cluster Randomised Trial
Video / Audio Recordings
Biography
Gareth Myring is a research associate in health economics at NIHR ARC West and the University of Bristol where he works on health economic analyses for studies based within the delivery of healthcare.
Dr Daniel O'Keefe
Senior Research Officer
Burnet Institute
#VP45: Partnering Peer Specialists With Nurses To Expand Access To Hepatitis C Care For People Who Inject Drugs: The Path-Expanded Evaluation
Video / Audio Recordings
Biography
Dr. Daniel O'Keefe has been working in the field of drug and alcohol and disease elimination work since 2010. He has a particular interest in global hepatitis C elimination, particularly among populations most at-risk, such as people who inject drugs.
Dr David Ortiz-Paredes
Research Assistant
Research Institute of the McGill University Health Centre
#VP46: Interventions To Improve The Uptake Of Direct-Acting Antivirals In High- And Middle-Income Countries: A Systematic Review
Video / Audio Recordings
Biography
Colombian general practitioner holding a MSc in Family Medicine from McGill University. Dr. Ortiz-Paredes current work involves systematic reviews and qualitative studies on Hepatitis C elimination, and HIV conducted at the Chronic Viral Illness Service (CVIS) of the Research Institute of the McGill University Health Centre (RI-MUHC).
Dr Emily Ower
Family Physician
Vancouver Coastal Health
#VP47: Improving Complete Screening For Hepatitis C Vertical Transmission In The Perinatal Period
Video / Audio Recordings
Biography
Dr Emily Ower is a recent graduate from the University of British Columbia’s Indigenous Family Medicine residency program. She holds her MD from the University of Calgary and her BA & Sc from McGill University. Her interests include perinatal addictions and culturally safe medicine for Indigenous patients.
Dr Adam Palayew
Postdoc
Simon Fraser University
PhD Irene Pericot-Valverde
Research Assistant Professor
Clemson University
#VP49: More Intensive HCV-Care Promotes Adherence Among People Who Inject Drugs With Recent Drug Use
Video / Audio Recordings
Biography
Dr. Pericot-Valverde is an Assistant Professor at Clemson University and the Project Director of the HERO Study. She is an early-career investigator committed to pursuing research in the field of addiction.
Mr James Plant
Clinical Nurse Specialist
Swansea Bay University Health Board
#PO38: Improving Access To HCV Therapy In HMP Swansea Using A Novel Point Of Care Testing Strategy And An Accelerated Pathway To Treatment
Speaker Presentation
Video / Audio Recordings
Biography
James began his nursing career tackling infectious conditions within the remand prison population in South West Wales. He is now a clinical nurse specialist in the field of blood-borne virus outreach with particular interest in novel screening strategies among marginalised groups.
Ms Lucy Ralton
Nurse Consultant
Sa Health
#VP43: PROMPt – Point Of Care Testing For Hepatitis C In The Priority Settings Of Mental Health, Prisons And Drug & Alcohol Facilities
Video / Audio Recordings
Biography
Lucy Ralton is a Nurse Consultant who has worked in Viral hepatitis, Hepatology and clinical research since 2011. She is passionate about the provision of equitable healthcare to people from disadvantaged backgrounds and has worked in Adelaide’s Northern suburbs since 2014. She is the project lead for the PROMPt study.
Mrs Fiona Rees
Highly Specialized Pharmacist - Gastroenterology
University Hospitals Sussex NHS Foundation Trust
#PO39: Can The Online Shopping Model ‘Lock-Box Delivery’ Improve Hepatitis C Treatment Access Amongst Vulnerable Adults?
Video / Audio Recordings
Biography
Fiona is a Non-Medical Prescribing Highly Specialist Gastroenterology Pharmacist, focussing on autoimmune hepatitis, viral hepatitis and IBD. In 2015 she was awarded RPS Faculty Advanced Practice and in 2020 the Chief Pharmaceutical Officer’s Global Health Fellowship. Fiona is on the UKCPA-Gastroenterology and BASL-British Pharmacy Hepatology Group education committees.
Carolin Reese
Nurse/socialworker
Drogenberatung E.v. Bielefeld
#VP50: How To Get Access To Most Vulnerable Groups To Identify And Treat HCV (Hepatitis C)
Biography
-Study of medicine in Marburg
-Specialist internal medicine
- head of the HIV-ambulance
-Departmentmanager (Clinic Mara II-EvKB Bielefeld)
-currently: Drogenberatung e.V. Bielefeld (head of medical supply in "all-in-one-place-offer"
Ms Ana Romero
Women's Health Program Manager
Sydney Local Health District
#PO40: Non-Clinical Service Provision Of HIV And Hepatitis C Dried Blood Spot Testing In Community Settings
Speaker Presentation
Video / Audio Recordings
Biography
Ana is a medical doctor from Spain with a great interest in public health. My experience in Australia and overseas encompasses work in clinical practice, health promotion and community education.
Amy Sargent
Conference Operations & Account Manager
ASHM
AAA
Biography
Msc Tanja Schwarz
Researcher
Austrian Public Health Institute (Gesundheit Österreich)
#VP52: Interventions To Increase Linkage To Care And Adherence To Treatment For Hepatitis C Among People Who Inject Drugs : A Systematic Review
Video / Audio Recordings
Biography
Tanja Schwarz is a junior researcher in the field of drug-related epidemiology and addiction at the Austrian Public Health Institute (Gesundheit Österreich GmbH, GÖG). She is involved in various national and international projects on illicit drugs, drug consumption and resulting health consequences, drug-related infectious diseases and mortality.
Associate Professor Nick Scott
Head, Modelling & Biostatistics
Burnet Institute
#VP53: A Modelling Analysis Of Financial Incentives For Hepatitis C Testing And Treatment Uptake Delivered Through A Community-Based Testing Campaign
Biography
Dr Nick Scott is the Head of Modelling & Biostatistics at the Burnet Institute. His research generates economic arguments for better health policy, particularly for improving access to viral hepatitis testing, treatment and care.
Dr. Andrew Seaman
Assistant Professor Of Medicine
Oregon Health And Sciences University / Central City Concern
#PO41: A Novel Hepatitis C “Treatment-Ready” Self-Collect Panel: HIV, Hepatitis B Surface Antigen, Hepatitis B Core Antibody, And Hepatitis C RNA On Dried Blood Spot And Serum Separating Cards
Speaker Presentation
Biography
Andrew Seaman is an assistant professor of medicine at Oregon Health & Science University. He is an addiction medicine and hepatitis C researcher, and the director of hepatitis and HIV services at Central City Concern. His research passions center on the intersection of hepatitis C and injection drug use.
Dr. Andrew Seaman
Assistant Professor Of Medicine
Oregon Health And Sciences University / Central City Concern
#VP54: Evaluation Of A Novel Reflexive Laboratory Bundle Combining Screening And Workup In A Hepatitis C Elimination Program
Video / Audio Recordings
Biography
Andrew Seaman is an assistant professor of medicine at Oregon Health & Science University. He is an addiction medicine and hepatitis C researcher, and the director of hepatitis and HIV services at Central City Concern. His research passions center on the intersection of hepatitis C and injection drug use.
Ms Leah Shaw
Data Manager
Boston Health Care For The Homeless Program
#PO42: From Treatment Initiation To Cure: Movement Along The HCV Care Cascade Among Homeless And Unstably Housed Individuals Who Inject Drugs
Video / Audio Recordings
Biography
Leah Shaw is the Data Manager for the HCV and HIV teams at Boston Healthcare for the Homeless Program. She leads quality improvement projects, reporting, and research. She enjoys communicating data to diverse teams and using analyses to improve care. She completed her MPH at Tufts University in 2017.
Dr Yumi Sheehan
Senior Research Fellow
Kirby Institute
#PO43: Improving Public Health Literacy With Sector-Wide Hepatitis C Education In Australian Prisons
Video / Audio Recordings
Biography
Yumi is a project coordinator and PhD student at the Kirby Institute UNSW Sydney, currently working across multiple HCV and prison-related research studies and initiatives. Yumi’s PhD focusses on strategies to enhance access to HCV testing and treatment for prisoners, with a particular focus on point-of-care testing and education.
Dr Ash Stewart
Researcher
Burnet Institute
#VP56: Opportunity For Targeted Hepatitis C Health Messaging For Sub-Populations Of People Who Inject Drugs In Melbourne: A Latent Class Analysis
Video / Audio Recordings
Biography
Ash is a PhD student with the Public Health discipline at the Burnet Institute. Ash works on the Prison and Transition to Health (PATH) study and the SuperMIX cohort study of people who inject drugs in Melbourne.
Professor Vana Sypsa
Professor Of Epidemiology And Medical Statistics
National And Kapodistrian University Of Athens
#VP57: Cascade Of HCV Care Among People Who Inject Drugs In Athens, Greece: Aristotle HCV-HIV Programme
Video / Audio Recordings
Biography
Vana Sypsa is Associate Professor of Epidemiology and Medical Statistics in the National and Kapodistrian University of Athens, Greece. Her research interests are focused on viral hepatitis and HIV. She is principal investigator in multiple community-based and prison-based programs targeting the population of PWID in Greece.
Mr Gunnar Thingnes
Leader
Sykepleie på hjul, Fransiskushjelpen
Dr Jorge Antonio Valencia La Rosa
Medical Specialist
Hospital Universitario Infanta Leonor
#VP58: Differences In The Hepatitis C Virus Cascade Of Care And Time To Initiation Of HCV Therapy Among Vulnerable Subpopulations Using A Mobile Unit As The Point-Of-Care
Video / Audio Recordings
Biography
Dr. Valencia is medical coordinator of a mobile harm reduction unit in Madrid, Spain.He attend PWID with diseases related to injection drug use. He is involved in researches regarding to bacterial and viral infections occurring in PWID and other vulnerable groups.In addition, he works in the Infanta Leonor Hospital (Madrid)
Dr. Win Lei Yee
Program Manager
Burnet Institute
#VP41: Acceptability Of Community-Based Hepatitis C Testing And Treatment Among People Who Inject Drugs In Yangon, Myanmar
Video / Audio Recordings
Biography
Win Lei is a medical doctor and a public health practitioner, with extensive experience in humanitarian and development work. She is currently working with Burnet Institute on research projects related to HIV and Hepatitis C. Win Lei holds a degree in Master of Public Health from the University of Melbourne.
